Propolis enhances adipocyte differentiation and prevents insulin resistance in 3T3-L1 cells (propolis improves insulin resistance in vitro)

Nippon Shokuhin Kagaku Kogaku Kaishi

Volumn 56, Issue 1, 2009, Pages 31-39

  Aga, Miho ^a   Arai, Norie ^a   Ohashi, Emiko ^a   Ariyasu, Toshio ^a   Arai, Shigeyuki ^a   Iwaki, Kanso ^a   Ohta, Tsunetaka ^a   Fukuda, Shigeharu ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

3T3 L1; Adiponectin; Insulin resistance; PPAR propolis extract; Preadipocyte

Indexed keywords

EID: 62549144845     PISSN: 1341027X     EISSN: None     Source Type: Journal    
DOI: 10.3136/nskkk.56.31     Document Type: Article

References (28)

1. Yamamoto, Y., Hirose, H., Saito, I., Tomita, M. Taniyama, M., Matsubara, K., Okazaki, Y., Ishii, T., Nishikai, K. and Saruta, T. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin. Sci., 103, 137-142 (2002).
2. Ebinc, H., Ozkurt, ZN., Ebinc, FA., Yilmaz, M. and Caglayan, O. Adiponectin and insulin resistance in obesity-related diseases. J. Int. Med. Res., 36, 71-79 (2008).
3. Guo, D. and Donner, DB. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem., 271, 615-618 (1996).
4. Peraldi, P., Hotamisligil, GS., Buurman, WA, White, MF. and Spiegelman, BM. Tumor necrosis factor (TNF)- ainhibits insulin signaling through stimulation of the p 55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem., 271, 13018-13022 (1996).
5. 307 via distinct pathways. J. Clin. Invest., 107, 181-189 (2001).
6. Yu, JG., Javorschi, S., Hevener, AL., Kruszynska, YT., Norman, RA., Sinha, M. and Olefsky, JM. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 51, 2968-2974 (2002).
7. Miyazaki, Y., Mahankali, A., Wajcberg, E., Bajaj, M., Mandarino, LJ. and DeFronzo, RA. Effect of piogli- tazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab., 89, 4312-4319 (2004).
8. Nagashima, K., Lopez, C, Donovan, D., Ngai, C, Fontanez, N., Bensadoun, A., Fruchart-Najib, J., Holleran, S., Cohn, JS., Ramakrishnan, R. and Ginsberg, HN. Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J. Clin. Invest, 115, 1323-1332 (2005).
9. Aga, H., Shibuya, T., Sugimoto, T., Kurimoto, M. and Nakajima, S. Isolation and Identification of antimicrobial compounds in Brazilian propolis. Biosci. Biotech. Biochem., 58, 945-946 (1994).
10. Hashimoto, T., Aga, H., Tabuchi, A., Shibuya, T., Chaen, H., Fukuda, S. and Kurimoto, M. Anti-Hericobacter Pylori compounds in Brazilian ropolis. Nat. Med, 52, 518-520 (1998).
11. Tatefuji, T., Izumi, N., Ohta, T., Arai, S., Ikeda, M. and Kurimoto, M. Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. Biol. Pharm Bull, 19, 966-970 (1996).
12. Shimizu, K., Ashida, H., Matsuura, Y. and Kanazawa, K. Antioxidative bioavailability of artepillin C in Brazilian propolis. Arch. Biochem. Biophys., 424, 181-188 (2004).
13. Tan-no, K., Nakajima, T., Shoji, T., Nakagawasai, O., Niijima, F., Ishikawa, M., Endo, Y., Sato, T., Satoh, S. and Tadano, T. Anti-inflammatory effect of propolis through inhibition of nitric oxide production on carrageenin- induced mouse paw edema. Biol. Pharm. Bull, 29, 96-99 (2006).
14. Orsolic, N., Terzic, S., Mihaljevic, Z., Sver, L. and Basic, I. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biol. Pharm. Bull, 28, 1928-1933 (2005).
15. Fuliang, HU., Hepburn, HR., Xuan, H., Chen, M., Daya, S. and Radloff, SE. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol. Res., 51, 147-152 (2005).
16. Green, H. and Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell, 5, 19-27 (1975).
17. Japanese source
18. Marcucci, MC, Ferreres, F., Custodio, AR., Ferreira, MM., Bankova, VS., Garcia-Viguera, C. and Bretz, WA. Evaluation of phenolic compounds in Brazilian propolis from different geographic regions. Z. Naturforsch., 55, 76-81 (2000).
19. Tazawa, S., Warashina, T. and Noro, T. On the chemical evaluation of propolis. Nat. Med., 54, 306-313 (2000).
20. Mishima, S., Ono, Y., Araki, Y., Akao, Y. and Nozawa, Y. Two related cinnamic acid derivatives from Brazilian honey bee propolis, baccharin and drupanin, induce gwowth inhibition in allografted sarcoma S-180 in mice. Biol. Pharm. Bull, 28, 1025-1030 (2005).
21. Volpi, N. and Bergonzini, G. Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry. J. Pharm. Biomed. Anal, 42, 354-361 (2006).
22. Adisakwattana, S., Roengsamran, S., Hsu, WH. and Yibchok-anun, S. Mechanisms of antihyperglycemic effect of p-methoxycinnamic acid in normal and strepto- zotocin-induced diabetic rats. Life Sci, 78, 406-412 (2005).
23. Jung, UJ., Lee, MK., Park, YB., Jeon, SM. and Choi, MS. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J. Pharmacol. Exp. Ther, 318, 476-483 (2006).
24. Tafuri, SR. Troglitazone enhances differentiation, basal glucose uptake, and Glutl protein levels in 3T3-L1 adipocytes. Endocrinol, 137, 4706-4712 (1996).
25. Cho, MC, Lee, WS., Hong, JT., Park, SW., Moon, DC, Paik, SG. and Yoon, DY. 5-(3, 5-Di-tert-butyl-4-hydroxy-benzylidene)thiazolidine-2, 4-dione modulates peroxisome proliferators-activated receptor gamma in 3T3-L1 adipocytes: roles as a PPARgamma ligand. Mol. Cell Endocrinol, 242, 96-102 (2005).
26. Ohsumi, J., Sakakibara, S., Yamaguchi, J., Miyadai, K., Yoshioka, S., Fujiwara, T., Horikoshi, H. and Serizawa, N. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinol, 135, 2279- 2282 (1994).
27. Szalkowski, D., White-carrington, S., Berger, J. and Zhang, B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinol, 136, 1474-1481 (1995).
28. Iwata, M., Haruta, T., Usui, I., Takata, Y., Takano, A., Uno, T., Kawahara, J., Ueno, E., Sasaoka, T., Ishibashi, O. and Kobayashi, M. Pioglitazone ameliorates tumor necrosis factor-α-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ-. Diabetes, 50, 1083-1092 (2001).